Even in the vastness of the American West, the new Porsche 911 Turbo S has the ability to shrink the landscape and compress time. It bends these forbidding, seemingly endless surroundings to its will ...

The General Motors Duramax turbodiesel engine family has evolved a lot since these heavy-duty pickup truck engines first came onto the scene in the early 2000s. Among the iterations of the Duramax ...

The short story here is that, no, electric turbochargers are not gimmicks. They're the real deal, with the ability to noticeably boost power and improve efficiency compared to the typical turbo units.

Eli Lilly (LLY) faces a downgrade to Reduce from HSBC analyst Rajesh Kumar, who cut his price target from $1,070 to $850, citing overestimated obesity drug market size ($80B-$120B by 2032 versus ...

Tue, March 17, 2026 at 4:25 PM UTC Kumar cut his target from $1,070 to $850, arguing that the obesity drug market's total addressable market is being overstated by investors. HSBC believes the obesity ...

Eli Lilly (LLY) has issued a public warning about potential safety risks associated with compounded tirzepatide mixed with vitamin B12. Lilly tested compounded products and found “significant levels ...

The truck may be totaled, but the 800HP compound turbo Cummins is still good. In this video, I start pulling the engine out of the wrecked frame to save the powerful setup and prepare it for the next ...

After experimenting in motorsports, Porsche introduced its first hybrid powertrain for a production car in 2013. Enthusiasts already know which one. The 918 Spyder was revolutionary, shifting the ...

CHONGQING, CHINA - JANUARY 29: In this photo illustration, a smartphone displays the logo of Eli Lilly and Company (NYSE: LLY), a U.S.-based pharmaceutical company specializing in prescription ...

Eli Lilly & Company (NYSE:LLY) ranks among the best high growth high margin stocks to buy now. Deutsche Bank retained its Buy rating and $1,200 price target for Eli Lilly & Company (NYSE:LLY) on ...

Eli Lilly LLY announced that it entered a definitive agreement to acquire the privately held clinical-stage biotech Orna Therapeutics in a deal valued at $2.4 billion. This transaction includes both ...